FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3113230733> ?p ?o ?g. }

• W3113230733 endingPage "128" @default.
• W3113230733 startingPage "123" @default.
• W3113230733 abstract "Abstract Background Previous studies have confirmed the safety and feasibility of half‐dose ticagrelor in Chinese patients with acute coronary syndrome, but currently there is no plan for the use of ticagrelor for Chinese ST‐segment elevation myocardial infarction (STEMI) patients. Hypothesis It is safe and feasible of low‐dose ticagrelor in patients with STEMI. Methods The STEMI patients who were undergoing emergency intervention and taking ticagrelor were enrolled. Patients whose level of platelet aggregation rate (PAR) less than 30% after 7‐day treatment with standard‐dose ticagrelor were randomly divided into low‐dose group (LD group, 45 mg twice daily) and standard‐dose group (SD group, 90 mg twice daily). The changes of levels of platelet parameters were compared between the two groups. The incidence of major adverse cardiac events (MACE), bleeding events were compared between the two groups within 6 months of follow‐up. Results The levels of PAR in the SD group decreased compared with baseline, and was lower than those of LD group at the same time point. The levels of platelet distribution width in both groups decreased from the baseline values (all p < .05) at 1, 3, and 6 months after grouping treatment, but there was no significant difference between the two groups. The incidence of MACE was similar between the two groups of patients. There were decreasing trends in the incidences of minimal bleeding event, minor bleeding event, dyspnea, and gout in the LD group. Conclusion It is safe and feasible of low‐dose ticagrelor for patients with STEMI based on the monitoring of PAR." @default.
• W3113230733 created "2020-12-21" @default.
• W3113230733 creator A5002287478 @default.
• W3113230733 creator A5013237430 @default.
• W3113230733 creator A5019240275 @default.
• W3113230733 creator A5021316973 @default.
• W3113230733 creator A5023986162 @default.
• W3113230733 creator A5028972050 @default.
• W3113230733 creator A5031213918 @default.
• W3113230733 creator A5072315367 @default.
• W3113230733 date "2020-12-15" @default.
• W3113230733 modified "2023-10-04" @default.
• W3113230733 title "Safety and feasibility of low‐dose ticagrelor in patients with ST ‐segment elevation myocardial infarction" @default.
• W3113230733 cites W1913813468 @default.
• W3113230733 cites W2017958214 @default.
• W3113230733 cites W2040234951 @default.
• W3113230733 cites W2060607835 @default.
• W3113230733 cites W2062627029 @default.
• W3113230733 cites W2078009181 @default.
• W3113230733 cites W2087951913 @default.
• W3113230733 cites W2088253386 @default.
• W3113230733 cites W2098118614 @default.
• W3113230733 cites W2105397247 @default.
• W3113230733 cites W2111862429 @default.
• W3113230733 cites W2140501627 @default.
• W3113230733 cites W2141358924 @default.
• W3113230733 cites W2167762095 @default.
• W3113230733 cites W2169387542 @default.
• W3113230733 cites W2295055355 @default.
• W3113230733 cites W2342241145 @default.
• W3113230733 cites W2726201926 @default.
• W3113230733 cites W2751087890 @default.
• W3113230733 cites W2793518888 @default.
• W3113230733 cites W2803567973 @default.
• W3113230733 cites W2809445717 @default.
• W3113230733 cites W2946028975 @default.
• W3113230733 cites W4211143229 @default.
• W3113230733 cites W4251834302 @default.
• W3113230733 doi "https://doi.org/10.1002/clc.23517" @default.
• W3113230733 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7803363" @default.
• W3113230733 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33320381" @default.
• W3113230733 hasPublicationYear "2020" @default.
• W3113230733 type Work @default.
• W3113230733 sameAs 3113230733 @default.
• W3113230733 citedByCount "0" @default.
• W3113230733 crossrefType "journal-article" @default.
• W3113230733 hasAuthorship W3113230733A5002287478 @default.
• W3113230733 hasAuthorship W3113230733A5013237430 @default.
• W3113230733 hasAuthorship W3113230733A5019240275 @default.
• W3113230733 hasAuthorship W3113230733A5021316973 @default.
• W3113230733 hasAuthorship W3113230733A5023986162 @default.
• W3113230733 hasAuthorship W3113230733A5028972050 @default.
• W3113230733 hasAuthorship W3113230733A5031213918 @default.
• W3113230733 hasAuthorship W3113230733A5072315367 @default.
• W3113230733 hasBestOaLocation W31132307331 @default.
• W3113230733 hasConcept C120665830 @default.
• W3113230733 hasConcept C121332964 @default.
• W3113230733 hasConcept C126322002 @default.
• W3113230733 hasConcept C164705383 @default.
• W3113230733 hasConcept C197934379 @default.
• W3113230733 hasConcept C2771771 @default.
• W3113230733 hasConcept C2777698277 @default.
• W3113230733 hasConcept C2780400711 @default.
• W3113230733 hasConcept C2780739214 @default.
• W3113230733 hasConcept C2780890252 @default.
• W3113230733 hasConcept C42219234 @default.
• W3113230733 hasConcept C500558357 @default.
• W3113230733 hasConcept C61511704 @default.
• W3113230733 hasConcept C71924100 @default.
• W3113230733 hasConceptScore W3113230733C120665830 @default.
• W3113230733 hasConceptScore W3113230733C121332964 @default.
• W3113230733 hasConceptScore W3113230733C126322002 @default.
• W3113230733 hasConceptScore W3113230733C164705383 @default.
• W3113230733 hasConceptScore W3113230733C197934379 @default.
• W3113230733 hasConceptScore W3113230733C2771771 @default.
• W3113230733 hasConceptScore W3113230733C2777698277 @default.
• W3113230733 hasConceptScore W3113230733C2780400711 @default.
• W3113230733 hasConceptScore W3113230733C2780739214 @default.
• W3113230733 hasConceptScore W3113230733C2780890252 @default.
• W3113230733 hasConceptScore W3113230733C42219234 @default.
• W3113230733 hasConceptScore W3113230733C500558357 @default.
• W3113230733 hasConceptScore W3113230733C61511704 @default.
• W3113230733 hasConceptScore W3113230733C71924100 @default.
• W3113230733 hasIssue "1" @default.
• W3113230733 hasLocation W31132307331 @default.
• W3113230733 hasLocation W31132307332 @default.
• W3113230733 hasOpenAccess W3113230733 @default.
• W3113230733 hasPrimaryLocation W31132307331 @default.
• W3113230733 hasRelatedWork W2017059309 @default.
• W3113230733 hasRelatedWork W2385143031 @default.
• W3113230733 hasRelatedWork W2801620844 @default.
• W3113230733 hasRelatedWork W2965155411 @default.
• W3113230733 hasRelatedWork W3000092873 @default.
• W3113230733 hasRelatedWork W3029448752 @default.
• W3113230733 hasRelatedWork W3039138000 @default.
• W3113230733 hasRelatedWork W3106881302 @default.
• W3113230733 hasRelatedWork W3115446225 @default.
• W3113230733 hasRelatedWork W4206977339 @default.

• next